Design
Other
Authors
Loading...
Facilitates standardized PRO assessment in trials and care; leaves open disease-specific validation in cardiovascular populations.
Cella et al. (2007) studied this question.
Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context: